Updates are available Correction dated 2021-06-10
Click to view Correction: https://doi.org/10.1038/s41392-021-00643-y
-
Authors
Lin, ChangDong
Li, Yue
Zhang, YueBin http://orcid.org/0000-0001-8174-7189
Liu, ZhaoYuan
Mu, Xia
Gu, Chenjian
Liu, Jing
Li, Yutang
Li, GuoHui
Chen, JianFeng http://orcid.org/0000-0002-2892-1691
- License Information
-
More Information
Article History
Received: 29 December 2020
Revised: 23 March 2021
Accepted: 31 March 2021
First Online: 18 May 2021
Change Date: 10 June 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41392-021-00643-y
Competing interests
: The authors have filed a patent (202110081412.2) for the application of ceftazidime and its derivatives in inhibiting SARS-CoV-2 infection.
